Zatebradine and exercise tolerance  by Boudoulas, Harisios & Leier, Carl V.
LETI-ERS TO THE EDITOR -- 
Dimensional&y of Flow Data 
Use of “three dimensional” in the title of the report on flow p&terns 
in the let? ventricle by Rim et al. (1) raises an issue of term;nolop. 
‘Three dimensional.” as used in that title. denoted acquisition of three 
directional components of velocity and not. as readers may inrtiahy 
have assumed data representing a threedimeMma1 volume. 
As acquisition of anatomic and flow data becomes more compre- 
hensive, either by mayetic resonance or by advanced ultrasound 
techniques, concise and unambiious terminology relating to dimen- 
siottality becomes mxesxuy. In accordance with echocardiiphic 
usage, I would propose the following conventions: Two d~mna.hnol or 
cross secrknra/ = acquisition in hw spnria/ dimensions of a plane. 781~ 
dime-/ = acquisition in all three spoti/ dimensions of a volume. 
Cine = acquisition of a temporal syence of data sets. In echocardi- 
ography, “real-rime” may be used, except when sequential image5 are 
reconstructed frao data acquired over longer periods of time. uben 
“ck’ is more appropkte. Two or three dire- = acquisihn of 
twoor three otthogonalcomponentsofveloctty (2). Either may&be 
called multidiiectkmal in that correlation of tw\-) or three components 
may reveal vectors in many direc& #IS. 
According to this terminology. Kim et al. acquired hvo- 
dimensional, rhreetional tine velocity data For comprehetie 
investigation of flow in the heart, three-dimemionaL threedirectional 
tine acquisition would be reqtired. To refer to this type of aquisitio~ 
‘kvcn diiionaj” has been used (3). but it is questionable whether 
measurement of a directional component of veti+ is equivalent tc 
dttermittatiort of location in the dimensions of space-time. F&x 
velocity comwnts are measured in relation t,, points a: re$ons 
located in space-time, but the converse 1s not true. 
Kilner has raised an important issue of tcrrnindogy m relatiin to 
dimensionaliry of tlow &&a. He suggests that dune dimenrianol hr used 
for sparid d; inemions or vdumes only and should not he used to 




report to which Kiln ‘r r&s (I), t!! title cutttains the wrds “three- 
ciimemiooal magnetic vzsomme vebxity.‘m ln this ca% -three- 
. . 
spnial variation In a more recent report tl) the t&e iTb;L~- 
dimensional reconstruckn of the tknv in a huslan left beart using 
magneiic resonance phase velocit) encoding” ir used. in this case. 
“threedimensionaf’ clearly refers to the spctal oration in the 
\elocity. not to its wctorial nature. Fur decades. a veiosic held has 
keen referred to b, itr dimensionalit) For instance. full) developed 
!aminar Thor in a pipe (Poiseuille flow 1 k onedimensional &N. That 
A. the %ekxny &es in the radial dkction on&. not in the &at or 
circumferential directions. Flow rn a cxr\ed tube h companwn ts 
three dimenvonal because it \arie< m the radkal. anal and cirrumfer- 
ential dire&n~. The imprtanr pint I< !hat th+se statements refer to 
the Hove held. not to the nature m uhich the f%.m held tvelocitv) IS 
meawred. Therefore. eren of the retin vcflor b measured at a single 
pint (e.g.. by laur Doppler anemornetr)). the rhreedimentionai 
selocie is still obtamed. 
Zatebradine and Exercise Tolerance 
We read uith interest tbe report tp Frtshman et al. t 1 t in a recent tssue 
of tbe JournaL The authors concluded that sinus r&e inhibition aith 
the bradyardii agent zatebradine ti not pr&de &icient antiin- 
ginaI and antikhemic effects to be useful for bttgtemt treatment in 
patienh with chronic angina *ho are takmg nifedipme. 
The authors 0Cered two ps&ie evpkeatrens for their hndmp. 
I ) The Bruce protccol used in the exerck mtght not he sufhcrenth 
msitive to the- reduckn in cardiac imhemia eapted to result from 
a decrease in heart rate of I? to 1-t beats min. 2 I The redxtron in heart 
mate might o&et an tiease in other determinants of myxardiil 
oxygen consumption. such as sentricutar prekod or mycardial con- 
tran;tIv 
Figum I. Relation between heart rate and percent drastole. Because 
of the nonlinear relation, smali changes in heart rate produce dramatic 
changes in percent diastole, especially at a slower heart rate. Reprinted 
with permksion t%rm Boudoulas et al. (4). 
TIX majority of coronary blood flow in normal humans occur in 
dlastole (3). In patients with coronary artery disease. systolic coronary 
Row is most likely lost because the perfusion pressure distal to the 
obshuctive lesions is less than the ventricular systolic and intramural 
systok pressure. In d&ok, coronary artery pressure distal to 4 
significant obstruction is low and probably does not change signifi- 
cantly with aortic pressure changes. When coronary perfusion pressure 
drops below a certain level, maximal vasodilation takes place. At this 
point, EW in the comprised coronary artery becomes dependent on 
diascdii perfush time as well as on ik perfusion pressure (3.4). 
Fen0 et al. (5) determined diastolic time. heart rate and rate- 
pressme pixxlwt in patienk with stabk angina pectoris at 0.1 -mV ST 
segment depm&on using supine and upright exercise and transesoph- 
agealp&gwithandwithouttherap=y.TheydemonstNt ed that heart 
rate, emxise time and rate-pressure product varied considerabiy at 
ischemic On&old (0.1 mV), whereas diastolic time was sinm;r 
regdess of the type of stress or status of therapy. ihe authors 
concluded that sttes+induced myocardiil ischemia occurs at “fixed” 
&tobctimeforeachindivi&lpatient. 
Two factors determine the duration of diifii perfusion time: 
l)heartrateand2)durationcfsystde,A~inheanrateors 
shortening of systole. or bth. will result in a prolongation of diastolic 
perhrsion tfme and vice versa. Because of the nonlinear relation 
betwen heart rate and diastohc myocardii perft&m time, small 
dtagesinheartratepoducesignilicantchangesindiastobictime(Fig. 
1). A dezteme in heart rat* ~75 beakmin produces a dramatic 
irlawse in diasmk time (4). 
PbprmrologiE Pgenkfan have a sign&ant effect on diastohc time. 














( plus zat&mhe) may pmduce a “Steal ptlenmenaL” lo 
Finre 2. A, Schematic of coronary artery resistance ir normal COIO- 
nary- artery and distal to a significant obstruction. Note hat coronary 
artery resistance distal to a significant obstruction is decreased com- 
pared to that in a normal coronary artery; flow thrr.@ collateral 
channels goes to the area perfused by the stenotic mrcnaty artery. 6, 
A potent arteriolar vasodilator will decrease significantly the resistance 
in the normal coronary artery but not the already low resistance, distal 
to coronary artery stenosis. Thus, the resistance in the normal coronary 
artery.and distal to significant stenosis will become ahnost equal, with 
resuhmg cessatkn of flow through collateral channels from the normal 
to the stenotic coronary artery. ‘I his phenomenon is known as thesteal 
phenomenon, and this pharmamiogic effect can be considered an 
ischemic one. Reprinted with permission from Boudoulas et al. (8). 
significant m: mary artery stenosis, coronary artery resistance distal to 
a significant obstruction is low compared with that of a normal 
coronary artery, and thus blood tends to Row through collateral 
channek from a normal coronary diitribution to that of the stenotic 
coronary artery (8) (Fig. 2). Potent arteriolar vasodilators decrease the 
-nary artery reststance in normal coronary vasatlature but hze 
much less effect on the vascular re&ance distal to the obstr&i 
This may result in a reduction in collateral flow or in an actual shiti of 
coronary blood flow through collateral chamrek from the region of the 
stenotic artery to that of a normal mronaq artery Collateral Row is a 
diastolic phenomenon. Thus, a reduction in heart rate, which increases 
diastolic time. may in the presence of maximal arteriolar vasodilation 
be accompanied by a steal phenomenon and be pmischemic. 
The recent study (I) showed that the admiition of ratebradine 
in patients treated with nifedipine does not increase exercise tolerance. 
However, it is not knosm whether ad&istration of nifedipine in 
patients treated with mtebradine will augment exercise tolerance. 
Studies have shown that combination therapy with cakium channel 
and beta-blockers increases exercise tolerance in patients wittt ano- 
nary artery disease. However, beta-blockers may prevent the steal 
phenomenon induced by nifedipine. Etecause studies have suggested 
thatin*easedsurvivalinrnroMlyaaerydise~seelatedtoadeaease 
in heart rate (2). a detrimental et%3 of nifediptne in patienk with 
coomary artery disease and a reduced heart rate cannot be excluded (9). 
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In response to Bootoulas and Leier, our findings with zatebndine do 
not just relate to a Jack of an additive e&t on exercise toterance when 
the drug is adminded to patients with angina ~wtoris already 
receiving nifediie (1). There are reports showing that zatebradine is 
Iem elk&e than long-acting dikiazem on exerck tolerana when 
uaedasmonotherapy(2)inp&entswithanginapectorisamJno 





both, may be more important than heart rate reduction in the 
an- effects of rate-lowering cabzium-entry and beta-adrenergic 
bhxking agents (4). Thii is also wggesmd by the wccemfnl experience 
ofMos3etal.(5)inusingintematpacingto bmease hearr rate when 
usinghigkdosebeta-blockadetonlievesymptornsinpatientswith 
refractory angina pectoris and bradyxrdia. 
We did not evaluate diasrolii time, systolic ejection tkx. col!ateraJ 
tin&m or indexes of ieti ventricular functmn in our study and m 
respondtosomeofthespeciticrematirsraisedbyBondoutasand 
bier. 
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Dobutamine Stress Echocardiography in 
Orthotopic Heart Transplant Recipients 
We read aith great interest the report by Derumeaua et al. (1) on the 
tyahmtion of transptdm coronary ark0 disease by dobutamine strew 
echocardiography. The authors deserve to be commended for using 
quantitative coronary angiograplry as the reference standard to com- 
pare the dobutamine stress echoc;lrd~phic lindii. However, we 
would like to comment on the methods utilized to cakulate sensitiuity. 
speciticity and positive sod negative predictive vahte~ which may have 
impurtant imphitions on their find&s. la their study (1). the authors 
wed quantitative coronary angkgmphy as the reference Standard to 
evaluate the d&o& accuracy of dobutamine stress echrxardiogra- 
pby in 37 patients They report a sensitivity and speciticity of 86% and 
91%. respectively. The prcbkm is that these values (sensiti.%y, 
spxikity, positive and negative predictive vahxs) are not bawd on 
the comparative anatjsis of the rerult.5 ef dobutamine stress ecbwar- 
diaphy versus those of quantitathe arronaty angiography. To 
derive the vahes the authors made two major assumptionz 1) Any 
indusibie wall motion abnormality observed was atMutable to the 
merepresenceoffocalepicor~an~lesiomrather 
than sigoifkant (>50%) tesiom. 2) Aft focal efkardial coronary 
ksions~makderedplqdbgMlysignificantregardlessddegree 
of stem For example, in theu study, seven patients with mihl 
arq&pphii kens (<40’S) were cons&d to have true positive 
results sddy on the basis of the positive results by M&amine stress 
edlocardicgraphy. clbvkdy, this creates major problems in the 
amdysis d send&y, spedicily and pxitive and negative predii 
acunacy. it is immktent 1~ fbst i..s a test (quantitative coromy 
angiographyinthircase)asi;refereoceaaodardto~~therxy~ 




“true positi” in the caknlation d sensirivitv, sqkxs&y and positive 
and negative prtdc& *abJes. 
Without adher&& to strict criteria bawd on quantitative at@gm- 
phy(refereoQdar,~),it~bedidiruhtolmosrthefabepaitiw 
rateof~stressectumrdiogqrhymheut~trecip 
ients Most illvc*m colT3ider ai% steno5is G3Q@+hk 
signifium stenosis (2-5). The authors cl?rrectly point m tk limit-a-- 
tionsdcoror~atya@ogra&in .assesngleriunseverit)iiahearl 
transplant re;ipienIs. cormury cza&p+y is Lunm 10 un&resti- 
matethesweri~oftnnk@ngcoronaryute~diiinbeart 
tramplam recipds (6). However. at present, it is prematore to 
ozinderlbbataminesnescdwmrdiopraphythedLgooslrtestd 
choicefc..nmnpbmtoaonvyvlerydiseaseandasasubstjnuefor 
cnronzq at+gn& as tk reference standard. 
